Poolbeg Pharma's book value per share for the quarter that ended in Dec. 2025 was $0.02.
During the past 12 months, Poolbeg Pharma's average Book Value Per Share Growth Rate was -36.80% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -31.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.
During the past 5 years, the highest 3-Year average Book Value Per Share Growth Rate of Poolbeg Pharma was -25.00% per year. The lowest was -31.30% per year. And the median was -28.15% per year.
Poolbeg Pharma's current price is $0.095. Its book value per share for the quarter that ended in Dec. 2025 was $0.02. Hence, today's PB Ratio of Poolbeg Pharma is 5.59.
During the past 5 years, the highest P/B Ratio of Poolbeg Pharma was 5.71. The lowest was 0.00. And the median was 0.00.
Poolbeg Pharma (OTCPK:POLBF) Book Value per Share Explanation
Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.
For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.
Poolbeg Pharma Book Value per Share Related Terms
Poolbeg Pharma Book Value per Share Historical Data
* Premium members only.
The historical data trend for Poolbeg Pharma's Book Value per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
POLBF vs VRTX, REGN, ALNY: Book Value per Share Comparison
For the Biotechnology subindustry, Poolbeg Pharma's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Poolbeg Pharma PB Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Poolbeg Pharma's PB Ratio distribution charts can be found below:
* The bar in red indicates where Poolbeg Pharma's PB Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Poolbeg Pharma (POLBF) has a Book Value per Share of $0.02 as of Dec. 2025. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Poolbeg Pharma and its competitors.
Is Poolbeg Pharma's Book Value per Share too high?
Poolbeg Pharma's current Book Value per Share is $0.02.
How does Poolbeg Pharma's Book Value per Share compare to VRTX and REGN?
Poolbeg Pharma's Book Value per Share of $0.02 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Book Value per Share for a Biotechnology company?
A good Book Value per Share depends on the Biotechnology industry context. However, Book Value per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Book Value per Share mean?
A high Book Value per Share can signal that a stock is expensive relative to its fundamentals. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Poolbeg Pharma and its competitors. Poolbeg Pharma's current Book Value per Share is $0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Poolbeg Pharma stock overvalued right now?
Poolbeg Pharma (POLBF) has a current Book Value per Share of $0.02. The current Book Value per Share is $0.02. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Book Value per Share calculated?
Book Value per Share is calculated from a company's financial statements. For Poolbeg Pharma (POLBF), the current Book Value per Share is $0.02 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Poolbeg Pharma PLC is a clinical-stage biopharmaceutical company with a core focus on transforming the cancer immunotherapy field. The Company's main asset, POLB 001, has the potential to expand administration of cancer immunotherapies from centralised specialist cancer centres into community hospitals by making the treatments safer through the prevention of the life-threatening side effect, Cytokine Release Syndrome (CRS). The group is also advancing the development of a patient-friendly therapy for obesity with an oral encapsulated GLP-1, offering a differentiated approach within one of the world's markets. It is focused on partnering its high-value programmes that are targeting large markets and addressing critical unmet medical needs.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
POLBF has been successfully added to your 